How have CMXC shares performed in 2024?

Cell MedX's stock was trading at $0.0220 on January 1st, 2024. Since then, CMXC stock has increased by 118.2% and is now trading at $0.0480. View the best growth stocks for 2024 here .

What other stocks do shareholders of Cell MedX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cell MedX investors own include Callon Petroleum (CPE) , Himax Technologies (HIMX) , Remark (MARK) , MicroVision (MVIS) , Ritter Pharmaceuticals (RTTR) , Linn Energy (LINEQ) , AudioEye (AEYE) , Bank of America (BAC) and Celldex Therapeutics (CLDX) .

How do I buy shares of Cell MedX?

Shares of CMXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:CMXC

Cell MedX (CMXC) Stock Price, News & Analysis

→ The Next Nvidia? (From InvestorPlace) (Ad)

Free CMXC Stock Alerts

$0.05

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.05
▼
$0.05
50-Day Range: $0.02
▼
$0.05
52-Week Range: $0.00
▼
$0.93

Volume: 30,520 shs
Average Volume: 23,804 shs
Market Capitalization: N/A

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Financials Headlines SEC Filings Short Interest

Get Cell MedX alerts:

Ad InvestorPlace

The Next Nvidia?

The Next Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the next Nvidia. Few in the media are talking about this story yet… but in the next 6 months that’s all they’ll talk about.

Go here now for this breaking story.

About Cell MedX Stock (OTCMKTS:CMXC)

Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson's disease, high blood pressure, neuropathy, and kidney functions. It develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual. The company also develops eBalance Home and eBalance Pro System for temporary relief of shoulder, waist, back, neck, arms, and legs. The company was formerly known as Sports Asylum, Inc. and changed its name to Cell MedX Corp. in September 2014. Cell MedX Corp. was incorporated in 2010 and is headquartered in Carson City, Nevada.

CMXC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CMXC Stock News Headlines

April 8, 2024 | americanbankingnews.com

Eargo (NASDAQ:EAR) & Cell MedX (OTCMKTS:CMXC) Critical Comparison

April 2, 2024 | businessinsider.com

The best cell phone plans in 2024

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 29, 2024 | bbc.co.uk

Cells, organ systems and ecosystems

March 29, 2024 | seekingalpha.com

CMXC Cell MedX Corp.

February 14, 2024 | bbc.co.uk

Cell structure - AQA Microscopes

February 14, 2024 | bbc.co.uk

Cell biology

January 10, 2024 | morningstar.com

Cell MedX Corp CMXC

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

December 19, 2023 | finance.yahoo.com

Cell MedX Corp. Announces New CEO and Directors and Debt Settlement

November 27, 2023 | finance.yahoo.com

Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order

November 9, 2023 | msn.com

Cell MedX says COO Costa resigns from the role

November 9, 2023 | finance.yahoo.com

Cell MedX Corp. Appoints Audit Committee and Accepts Resignation of Chief Operating Officer

November 2, 2023 | businessinsider.com

The best cheap cell phone plans in 2023

September 21, 2023 | bbc.co.uk

Cells of the nervous system, neurotransmitters at synapses

September 11, 2023 | bbc.co.uk

Chemical cells

September 11, 2023 | bbc.co.uk

Chemical cells and fuel cells

September 10, 2023 | bbc.co.uk

The cell membrane

April 27, 2023 | bbc.co.uk

Mitosis and the cell cycle

March 28, 2023 | bbc.co.uk

Division and differentiation in human cells

February 11, 2023 | bbc.co.uk

Cells and Reproduction

October 9, 2022 | usnews.com

Best Cell Phone Plans of 2022

October 2, 2022 | yahoo.com

3 Different Types of Fat Cells and How to Lose Them

September 20, 2022 | finance.yahoo.com

FDA Submission and Corporate Update

June 27, 2022 | finance.yahoo.com

Cell MedX Corp: Letter to Shareholders from Mr. Dwayne Yaretz, CEO

April 27, 2022 | seekingalpha.com

Cell MedX names new CEO

April 27, 2022 | finance.yahoo.com

Cell MedX Corp. Appoints Mr. Dwayne Yaretz as CEO and Director

See More Headlines

Receive CMXC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cell MedX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Medical Devices
Sub-Industry: N/A
Current Symbol: OTCMKTS:CMXC
Previous Symbol: NASDAQ:CMXC
CUSIP: N/A
CIK: 1493712
Web: cellmedx.com
Phone: (844) 238-2692
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

The Next 7 Blockbuster Stocks for Growth Investors

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

Ms. Yanika Silina C.M.A. (Age 46)
CPA, CFO, Treasurer, Corporate Secretary & Director
Comp: $30k
Mr. David M. Jeffs (Age 54)
President, CEO & Director

Key Competitors

View All Competitors

CMXC Stock Analysis - Frequently Asked Questions

How have CMXC shares performed in 2024?: Cell MedX's stock was trading at $0.0220 on January 1st, 2024. Since then, CMXC stock has increased by 118.2% and is now trading at $0.0480.
View the best growth stocks for 2024 here.
What other stocks do shareholders of Cell MedX own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Cell MedX investors own include Callon Petroleum (CPE), Himax Technologies (HIMX), Remark (MARK), MicroVision (MVIS), Ritter Pharmaceuticals (RTTR), Linn Energy (LINEQ), AudioEye (AEYE), Bank of America (BAC) and Celldex Therapeutics (CLDX).
How do I buy shares of Cell MedX?: Shares of CMXC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:CMXC) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial